Lipogems announces first patient enrolled in the U.S arise study for the treatment of knee osteoarthritis
ATLANTA, Jan. 13, 2023 /PRNewswire/ -- Lipogems, a clinical stage- global medical technology company, announces the first patient enrolled on January 13, 2023, in the ARISE U.S. FDA IDE study, which aims to examine...